Testing effectiveness (Phase 2)Study completedNCT00050349What this trial is testingEPO906 in Carcinoid and Other Neuroendocrine TumorsWho this might be right forCarcinoidNeuroendocrine Tumors Novartis Pharmaceuticals 33
Post-approval studies (Phase 4)Study completedNCT00204373What this trial is testingTreatment of Zollinger-Ellison Syndrome With PrevacidWho this might be right forZollinger-Ellison SyndromeMultiple Endocrine Neoplasia Charles Mel Wilcox, MD 72
Testing effectiveness (Phase 2)WithdrawnNCT04915144What this trial is testing177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETsWho this might be right forNeuroendocrine TumorsCarcinoid TumorPulmonary Carcinoid Tumor+4 more British Columbia Cancer Agency
Large-scale testing (Phase 3)Study completedNCT00079833What this trial is testingEsomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison SyndromeWho this might be right forZollinger-Ellison Syndrome AstraZeneca 25
Testing effectiveness (Phase 2)Study completedNCT00416767What this trial is testingCombination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By SurgeryWho this might be right forGastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome Federation Francophone de Cancerologie Digestive 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT01824875What this trial is testingTemozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+4 more ECOG-ACRIN Cancer Research Group 144
Testing effectiveness (Phase 2)Study completedNCT00001228What this trial is testingInterferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell CancerWho this might be right forIslet Cell AdenomaZollinger Ellison Syndrome National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Not applicableActive Not RecruitingNCT03583528What this trial is testingDOTATOC PET/CT for Imaging NET PatientsWho this might be right forNeuroendocrine TumorsInsulinomaGastrinoma+13 more British Columbia Cancer Agency 800
Early research (Phase 1)Study completedNCT00655655What this trial is testingEverolimus and Vatalanib in Treating Patients With Advanced Solid TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+17 more Mayo Clinic 96
Testing effectiveness (Phase 2)Study completedNCT00027638What this trial is testingThalidomide in Treating Patients With Metastatic Neuroendocrine TumorsWho this might be right forGastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+1 more Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)WithdrawnNCT00227773What this trial is testingVatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine TumorsWho this might be right forGastrointestinal Carcinoid TumorIslet Cell Carcinoma Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00131911What this trial is testingSorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+7 more National Cancer Institute (NCI) 93
Testing effectiveness (Phase 2)Study completedNCT01010126What this trial is testingTemsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerWho this might be right forAdult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more National Cancer Institute (NCI) 252
Testing effectiveness (Phase 2)Ended earlyNCT02454075What this trial is testingYF476 and Type II Gastric CarcinoidsWho this might be right forZollinger-Ellison Syndrome Trio Medicines Ltd. 3
Testing effectiveness (Phase 2)WithdrawnNCT02108782What this trial is testingDovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+3 more Academic and Community Cancer Research United
Testing effectiveness (Phase 2)Study completedNCT00602082What this trial is testingCapecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine TumorsWho this might be right forGastrointestinal Carcinoid TumorIslet Cell Tumor Cambridge University Hospitals NHS Foundation Trust 84
Testing effectiveness (Phase 2)Study completedNCT00001165What this trial is testingCombination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the PancreasWho this might be right forIslet Cell AdenomaNeoplasm MetastasisZollinger Ellison Syndrome National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 999
Large-scale testing (Phase 3)Study completedNCT02153398What this trial is testingA Phase I/III Study of D961H 10 mg and 20 mg in Japanese Paediatric Patients With Gastrointestinal Acid Related DiseasesWho this might be right forGastric Ulcer (GU)Duodenal Ulcer (DU)Anastomotic Ulcer (AU)+3 more AstraZeneca 55
Testing effectiveness (Phase 2)Ended earlyNCT02031536What this trial is testingEverolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With SurgeryWho this might be right forGastrinomaGlucagonomaInsulinoma+4 more ECOG-ACRIN Cancer Research Group 2